Related Experiment Video

Updated: Feb 9, 2026

Robust Differentiation of Human iPSCs into a Pure Population of Adipocytes to Study Adipocyte-Associated Disorders
10:31

Robust Differentiation of Human iPSCs into a Pure Population of Adipocytes to Study Adipocyte-Associated Disorders

Published on: February 9, 2022

4.2K

Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro

Alberto Camacho1,2,3, Juan Carlos Segoviano-Ramírez4,5, Adriana Sánchez-Garcia6

  • 1Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León (UANL), Monterrey, Mexico. acm590@hotmail.com.

Lipids in Health and Disease
|May 31, 2018
PubMed
Abstract

Insights

Tyrphostin (T-AG17) effectively inhibits adipocyte differentiation and reduces fat accumulation in obesity models. This compound promotes adipocyte apoptosis, suggesting its potential as a novel pharmacological treatment for obesity.

Area of Science:

  • Biochemistry
  • Metabolic disease research
  • Pharmacology

Background:

  • Obesity is linked to increased white adipose tissue (WAT) differentiation and expansion.
  • The insulin inhibitor and mitochondrial uncoupler Tyrphostin (T-AG17) was investigated for its effects on adipogenesis.

Purpose of the Study:

  • To investigate the in vitro and in vivo effects of T-AG17 on adipocyte differentiation and hypertrophy.
  • To evaluate T-AG17's safety and metabolic impact in a diet-induced obesity mouse model.

Main Methods:

  • 3T3-L1 proadipocyte cell line used for in vitro differentiation studies.
  • Diet-induced obesity model in C57BL/6 mice to assess T-AG17 effects on physiological and molecular parameters.
  • Analysis included adipogenesis, lipid accumulation, apoptosis (caspase-3), and serum biochemistry.

Main Results:

  • T-AG17 significantly inhibited adipogenesis and lipid synthesis in 3T3-L1 cells (p < 0.05).
  • Oral T-AG17 administration in obese mice reduced fat accumulation and WAT hypertrophy.
  • T-AG17 induced adipocyte apoptosis via caspase-3 activation and increased lipid/glycogen in hepatocytes without altering key serum markers.

Conclusions:

  • T-AG17 effectively inhibits adipocyte differentiation and WAT hypertrophy in vitro and in vivo.
  • T-AG17 promotes adipocyte apoptosis, indicating its potential as a pharmacological obesity treatment.
Keywords:
AG17Adipocyte differentiationAdipogenesisHepatic steatosisMitochondrial uncouplingObesityOxidative phosphorylationThermogenesisTyrphostin

More Related Videos

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.8K
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

3.5K

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.3K
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
239
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.7K
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
283
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Implicit Differentiation01:25

Implicit Differentiation

In classical mechanics, motion is often described through relationships between spatial coordinates and time. A car moving along a straight highway with constant acceleration serves as a simple case where velocity is an explicit function of time. This scenario results in a linear equation, enabling straightforward analysis using basic differentiation techniques.In contrast, a satellite in circular orbit follows a path defined by an implicit function. The position of the satellite is constrained...
68